Patients with schizophrenia and the AG genotype may have an increased response to risperidone as compared to patients with the GG genotype but a decreased response as compared to patients with the AA genotype. However, this association was only found in a subanalysis of symptoms scores while another study failed to find an association. Other genetic and clinical factors may also affect a patient's response to risperidone.